#4913 ANALYSIS OF THE LIPID PROFILE IN THE RENAL PATIENT AND SUB-ANALYSIS OF THE POPULATION WITH POLYCYSTIC KIDNEY DISEASE

Abstract Background and Aims Dyslipidemia is frequent in patients with chronic kidney disease (CKD), it constitutes a factor of progression both cardiovascular risk (CVR) CKD itself. It has its own characteristics, which are modified the ERC stadium. The subgroup Polycystic Kidney Disease (PKD) presents characteristics. aim study was to analyze lipid profile renal population differences PKD group. Method Retrospective observational study, includes under follow-up nephrology consultations health area, during 2018–2021. We analyzed profile, function whether they received statins. IBM SPSS Statistics V24 used. Results 3301 prevalent were collected, excluding those on replacement therapy (RRT), glomerular filtration rate (GFR), (GFR) <10ml/min/1.73m² proteinuria greater than 1.5g. Of these, 112 (3.4%) had PKD. 51% total treatment average number Total Cholesterol (TC) 170.4+/-43mg/dl, LDL 92.3+/-37mg/dl, HDL 50.3+/-15mg/dl triglycerides (TG) 147.3+/-92mg/dl. In 37% patients, >100mg/dl only 35% LDL<75mg/dl. group GFR <60ml/min/1.73m² (N = 2337; 71%), there high prevalence values 784; 33.5%). case <30ml/min/1.73m² 981; 29.7%), presence LDL>100mg/dl 30% 297) also frequent. subanalysis PKD, mean TC 182+/-40mg/dl, 101.2+/-33mg/dl, 56.4+/-17mg/dl, TG 123.7+/-59mg/dl. 76% 73), 43% presented 32). > 60ml/min/1.73m² 39), half 22; 56.4%) >100mg/dl. addition, taking statin, despite this 183mg/dl+/-46, 102.7+/-39, 53+/-15, 142+/-69mg/dl. Conclusion elevated CKD, especially < without statin quarter same statin. notable group, probably due less awareness strict CVR control.